Lancet. 2017 Jul 15;390(10091):231-266. doi: 10.1016/S0140-6736(17)30818-8. Epub 2017 May 18.
National levels of personal health-care access and quality can be approximated by measuring mortality rates from causes that should not be fatal in the presence of effective medical care (ie, amenable mortality). Previous analyses of mortality amenable to health care only focused on high-income countries and faced several methodological challenges. In the present analysis, we use the highly standardised cause of death and risk factor estimates generated through the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) to improve and expand the quantification of personal health-care access and quality for 195 countries and territories from 1990 to 2015.
We mapped the most widely used list of causes amenable to personal health care developed by Nolte and McKee to 32 GBD causes. We accounted for variations in cause of death certification and misclassifications through the extensive data standardisation processes and redistribution algorithms developed for GBD. To isolate the effects of personal health-care access and quality, we risk-standardised cause-specific mortality rates for each geography-year by removing the joint effects of local environmental and behavioural risks, and adding back the global levels of risk exposure as estimated for GBD 2015. We employed principal component analysis to create a single, interpretable summary measure-the Healthcare Quality and Access (HAQ) Index-on a scale of 0 to 100. The HAQ Index showed strong convergence validity as compared with other health-system indicators, including health expenditure per capita (r=0·88), an index of 11 universal health coverage interventions (r=0·83), and human resources for health per 1000 (r=0·77). We used free disposal hull analysis with bootstrapping to produce a frontier based on the relationship between the HAQ Index and the Socio-demographic Index (SDI), a measure of overall development consisting of income per capita, average years of education, and total fertility rates. This frontier allowed us to better quantify the maximum levels of personal health-care access and quality achieved across the development spectrum, and pinpoint geographies where gaps between observed and potential levels have narrowed or widened over time.
Between 1990 and 2015, nearly all countries and territories saw their HAQ Index values improve; nonetheless, the difference between the highest and lowest observed HAQ Index was larger in 2015 than in 1990, ranging from 28·6 to 94·6. Of 195 geographies, 167 had statistically significant increases in HAQ Index levels since 1990, with South Korea, Turkey, Peru, China, and the Maldives recording among the largest gains by 2015. Performance on the HAQ Index and individual causes showed distinct patterns by region and level of development, yet substantial heterogeneities emerged for several causes, including cancers in highest-SDI countries; chronic kidney disease, diabetes, diarrhoeal diseases, and lower respiratory infections among middle-SDI countries; and measles and tetanus among lowest-SDI countries. While the global HAQ Index average rose from 40·7 (95% uncertainty interval, 39·0-42·8) in 1990 to 53·7 (52·2-55·4) in 2015, far less progress occurred in narrowing the gap between observed HAQ Index values and maximum levels achieved; at the global level, the difference between the observed and frontier HAQ Index only decreased from 21·2 in 1990 to 20·1 in 2015. If every country and territory had achieved the highest observed HAQ Index by their corresponding level of SDI, the global average would have been 73·8 in 2015. Several countries, particularly in eastern and western sub-Saharan Africa, reached HAQ Index values similar to or beyond their development levels, whereas others, namely in southern sub-Saharan Africa, the Middle East, and south Asia, lagged behind what geographies of similar development attained between 1990 and 2015.
This novel extension of the GBD Study shows the untapped potential for personal health-care access and quality improvement across the development spectrum. Amid substantive advances in personal health care at the national level, heterogeneous patterns for individual causes in given countries or territories suggest that few places have consistently achieved optimal health-care access and quality across health-system functions and therapeutic areas. This is especially evident in middle-SDI countries, many of which have recently undergone or are currently experiencing epidemiological transitions. The HAQ Index, if paired with other measures of health-system characteristics such as intervention coverage, could provide a robust avenue for tracking progress on universal health coverage and identifying local priorities for strengthening personal health-care quality and access throughout the world.
Bill & Melinda Gates Foundation.
通过测量在有效医疗护理存在时不应致命的病因导致的死亡率,可以近似估算国家层面的个人医疗保健可及性和质量(即可避免死亡率)。以往对可通过医疗保健避免的死亡率的分析仅聚焦于高收入国家,且面临若干方法学挑战。在本分析中,我们使用通过全球疾病、伤害及风险因素负担研究(GBD)生成的高度标准化的死因和风险因素估计值,以改进和扩展对1990年至2015年期间195个国家和地区的个人医疗保健可及性和质量的量化。
我们将诺尔特和麦基编制的最广泛使用的个人医疗保健可及病因清单映射到32个GBD病因。我们通过为GBD开发的广泛数据标准化流程和重新分配算法,考虑了死因认证的差异和错误分类。为了分离个人医疗保健可及性和质量的影响,我们通过消除当地环境和行为风险的联合影响,并重新加入GBD 2015估计的全球风险暴露水平,对每个地理区域-年份的特定病因死亡率进行风险标准化。我们采用主成分分析来创建一个单一的、可解释的汇总指标——医疗保健质量与可及性(HAQ)指数,范围为0至100。与其他卫生系统指标相比,HAQ指数显示出很强的收敛效度,包括人均卫生支出(r = 0·88)、11项全民健康覆盖干预措施的指数(r = 0·83)以及每千人口卫生人力资源(r = 0·77)。我们使用带自助法的自由处置壳分析,根据HAQ指数与社会人口指数(SDI)之间的关系生成一条前沿曲线,SDI是一个衡量总体发展水平的指标,由人均收入、平均受教育年限和总生育率组成。这条前沿曲线使我们能够更好地量化整个发展范围内个人医疗保健可及性和质量的最高水平,并确定随着时间推移观察到的水平与潜在水平之间差距缩小或扩大的地理区域。
1990年至2015年期间,几乎所有国家和地区的HAQ指数值都有所提高;尽管如此,2015年观察到的最高和最低HAQ指数之间的差异比1990年更大,范围从28·6到94·6。在195个地理区域中,自1990年以来,167个区域的HAQ指数水平有统计学显著提高,到2015年,韩国、土耳其、秘鲁、中国和马尔代夫的增幅最大。HAQ指数和个别病因的表现按地区和发展水平呈现出不同模式,但包括高SDI国家的癌症;中等SDI国家的慢性肾病、糖尿病、腹泻病和下呼吸道感染;以及低SDI国家的麻疹和破伤风等几种病因出现了显著的异质性。虽然全球HAQ指数平均值从1990年的40·7(95%不确定区间,39·0 - 42·8)上升到2015年的53·7(52·2 - 55·4),但在缩小观察到的HAQ指数值与最高水平之间的差距方面进展甚微;在全球层面,观察到的HAQ指数与前沿HAQ指数之间的差异仅从1990年的21·2降至2015年的20·1。如果每个国家和地区都能在其相应的SDI水平上达到观察到的最高HAQ指数,2015年的全球平均值将为73·8。几个国家,特别是撒哈拉以南非洲东部和西部的国家,达到了与它们的发展水平相似或超出其发展水平的HAQ指数值,而其他国家,即撒哈拉以南非洲南部、中东和南亚的国家,则落后于1990年至2015年期间类似发展水平的地理区域。
GBD研究的这一新颖扩展显示了整个发展范围内个人医疗保健可及性和质量改善的未开发潜力。在国家层面个人医疗保健取得实质性进展的同时,特定国家或地区个别病因的异质性模式表明,很少有地方在整个卫生系统功能和治疗领域持续实现最佳的医疗保健可及性和质量。这在中等SDI国家尤为明显,其中许多国家最近经历了或正在经历流行病学转变。如果将HAQ指数与其他卫生系统特征指标(如干预覆盖率)结合使用,可以为跟踪全民健康覆盖进展以及确定加强全球个人医疗保健质量和可及性的地方优先事项提供一个有力途径。
比尔及梅琳达·盖茨基金会